Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1. Romo CG, Sarin KY, Blakeley JO. Br J Dermatol 2024;190:145-146.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Romo CG, Sarin KY, Blakeley JO. Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1. Br J Dermatol 2024;190:145-146.
PMID: 38123358